ScholarIQanswers from OpenAlex & ORCID
Teresa Morán
ResearcherPublications, citations & collaboration network
Teresa Morán is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Teresa Morán have?
ScholarIQindexed works
Teresa Morán has 325 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Teresa Morán have?
ScholarIQcitation count
Teresa Morán has 18,945 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Teresa Morán?
ScholarIQh-index
Teresa Morán has an h-index of 50 in OpenAlex.
What is the i10-index of Teresa Morán?
ScholarIQi10-index
Teresa Morán has an i10-index of 107 in OpenAlex.
What is the ORCID of Teresa Morán?
ScholarIQorcid
The ORCID for Teresa Morán is on the source record.
What is the OpenAlex record for Teresa Morán?
ScholarIQopenalex
The OpenAlex for Teresa Morán is on the source record.
What are the most-cited papers on Teresa Morán?
ScholarIQmost cited works
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell, Enric Carcereny, Radj Gervais, A. Vergnenègre, Bartomeu Massutí, Enriqueta Felip, Ramón Palmero, Ramón García-Gómez, Cinta Pallarés, José Miguel Sánchez, Rut Porta, Manuel Cobo, Pilar Garrido, Flavia Longo, Teresa Morán, Amelia Insa, Filippo de Marinis, R. Corre, Isabel Bover, Alfonso Illiano, Éric Dansin, Javier de Castro, Michèle Milella, Noemı́ Reguart, Giuseppe Altavilla, Ulpiano Jiménez, Mariano Provencio, Miguel Ángel Moreno, Josefa Terrasa, José Muñoz-Langa, Javier Valdivia, Dolores Isla, Manuel Dómine, Olivier Molinier, Julien Mazières, Nathalie Baize, Rosario García‐Campelo, G. Robinet, Delvys Rodríguez‐Abreu, Guillermo López-Vivanco, Vittorio Gebbia, Lioba Ferrera-Delgado, P. Bombaron, Reyes Bernabé, Alessandra Bearz, Á. Artal, Enrico Cortesi, Christian Rolfo, María Sanchez-Ronco, Ana Drozdowskyj, Cristina Queralt, Itziar de Aguirre, José Luis Ramírez, José Javier Sánchez, Miguel Ángel Molina‐Vila, Miquel Tarón, Luis Paz‐Ares
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
Justin F. Gainor, Alice T. Shaw, Lecia V. Sequist, Xiujun Fu, Christopher G. Azzoli, Zofia Piotrowska, Tiffany G. Huynh, Ling Zhao, Linnea Fulton, Katherine R. Schultz, Emily Howe, Anna F. Farago, Ryan J. Sullivan, James R. Stone, Subba R. Digumarthy, Teresa Morán, Aaron N. Hata, Yukako Yagi, Beow Y. Yeap, Jeffrey A. Engelman, Mari Mino–Kenudson
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Matthew J. Niederst, Lecia V. Sequist, John T. Poirier, Craig H. Mermel, Elizabeth L. Lockerman, Angel R. Garcia, Ryohei Katayama, Carlotta Costa, Kenneth N. Ross, Teresa Morán, Emily Howe, Linnea Fulton, Hillary E. Mulvey, Lindsay A. Bernardo, Farhiya Mohamoud, Norikatsu Miyoshi, Paul A. VanderLaan, Daniel B. Costa, Pasi A. Jänne, Darrell R. Borger, Sridhar Ramaswamy, Toshi Shioda, A. John Iafrate, Gad Getz, Charles M. Rudin, Mari Mino–Kenudson, Jeffrey A. Engelman
Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer
Hiroyuki Yasuda, Eunyoung Park, Cai-Hong Yun, Natasha Sng, Antonio R. Lucena‐Araujo, Wee-Lee Yeo, Mark S. Huberman, David Cohen, Sohei Nakayama, Kota Ishioka, Norihiro Yamaguchi, Megan Hanna, Geoffrey R. Oxnard, Christopher S. Lathan, Teresa Morán, Lecia V. Sequist, Jamie E. Chaft, Gregory J. Riely, Maria E. Arcila, Ross A. Soo, Matthew Meyerson, Michael J. Eck, Susumu Kobayashi, Daniel B. Costa